User login


You are here

Application Engineer Biomedical (China)

Are you interested in being a part of our Materialise
high-end image processing software product? For our Biomedical Department we
are looking for motivated Application Engineers. 

The Mimics Innovation Suite is our world-leading image processing software for
(bio) medical researchers. Mimics® converts Medical Images into accurate 3D
models. As such it provides a link between MRI/CT images and Rapid Prototyping,
Finite Element analysis and CAD. The software is used in different application
areas, ranging from patient specific device design to population analyses. 
Among our customers are top universities, orthopedic and cardiac companies. 


As Application Engineer you are the bridge between the software development
team and the customer. You guide our customers – Biomechanical Engineers - by
giving training, support and by providing a proof of concepts. Through your
expertise and contact with the medical market, you will map the functional
needs of the market. You will translate these needs in requirements that will
lead to new tools in the Mimics software. You are responsible for writing,
documenting, follow up and validation of software project requirements. You will perform benchmark studies, and you
will assist in the organization of our Mimics Innovation Courses.


  • You possess a Masters Degree in Computer Sciences, Engineering (Biomedical,
    Mechanical, Others), Biomedical Sciences, Life Sciences, Biology, Science and
    Technology, Sport/Physical Education or equivalent and you have affinity with
    medical images and 3D designs. 
  • You have a natural interest in the medical world and innovative technologies. 
  • Knowledge of either Finite Element or CFD is a plus 
  • You are well organized, team oriented and you have good communication skills in
    English and Mandarin. 
  • You are willing to travel occasionally. 


Interested? Contact: 

Subscribe to Comments for "Application Engineer Biomedical (China)"

Recent comments

More comments


Subscribe to Syndicate